Risk Stratification in Pulmonary arterial Hypertension

被引：0

作者：

Meinrenken, Susanne

机构：

来源：

PNEUMOLOGIE | 2022年 / 76卷 / 03期

关键词：

D O I：

10.1055/a-1697-9846

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Auf der Grundlage der geschatzten 1-Jahres-Mortalitat von <5%, 5-10% oder >10% wird das Risiko eines Patienten mit Pulmonaler arterieller Hypertonie nach den EU-Leitlinien als niedrig, moderat oder hoch bewertet. Die Stratifikation gilt als entscheidend fur die Therapieplanung. Hoeper et al. pruften, ob sich mit einem Modell mit 4 Risikogruppen die Stratifizierung verbessern lasst.

引用

页码：156 / 157

页数：1

共 50 条

[41] Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
Richter, Manuel J.
Tello, Khodr
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (04) : 403 - 405
[42] Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension
Lewis, Robert A.
Johns, Christopher S.
Cogliano, Marcella
Capener, David
Tubman, Euan
Elliot, Charlie A.
Charalampopoulos, Athanasios
Sabroe, Ian
Thompson, A. A. Roger
Billings, Catherine G.
Hamilton, Neil
Baster, Kathleen
Laud, Peter J.
Hickey, Peter M.
Middleton, Jennifer
Armstrong, Iain J.
Hurdman, Judith A.
Lawrie, Allan
Rothman, Alexander M. K.
Wild, Jim M.
Condliffe, Robin
Swift, Andrew J.
Kiely, David G.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (04) : 458 - 468
[43] Machine Learning for Risk Stratification in Pulmonary Arterial Hypertension - Can It Achieve the Gold Standard?
Scott, Jacqueline M.
Kanwar, Manreet
Liu, Zilu
Lin, Shili
Antaki, James
Perer, Adam
Benza, Raymond L.
[J]. CIRCULATION, 2021, 144
[44] Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension
Kearney, K.
Anderson, J.
Cordina, R.
Lavender, M.
Celermajer, D.
Collins, N.
Corrigan, C.
Dwyer, N.
Feenstra, J.
Horrigan, M.
Keating, D.
McWilliams, T.
Rhodes, B.
Williams, T.
Whitford, H.
Whyte, K.
Weintraub, R.
Wrobel, J.
Keogh, A.
Kotlyar, E.
Lau, E.
[J]. RESPIROLOGY, 2022, 27 : 51 - 51
[45] Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension
Kearney, K.
Anderson, J.
Cordina, R.
Lavender, M.
Celermajer, D.
Collins, N.
Dwyer, N.
Keating, D.
Williams, T.
Whitford, H.
Whyte, K.
Weintraub, R.
Keogh, A.
Kotlyar, E.
Lau, E. M. T.
[J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1958 - 1958
[46] Role of the electrocardiogram in the risk stratification of pulmonary hypertension
Hendriks, Paul M.
Kauling, Robert M.
Geenen, Laurie W.
Eindhoven, Jannet A.
Roos-Hesselink, Jolien W.
Boomars, Karin A.
van den Bosch, Annemien E.
[J]. HEART, 2023, 109 (03) : 208 - 215
[47] Assessment of the Pulmonary Arterial Remodeling and the Risk Stratification Score During Shortterm Follow-up in Prevalent Pulmonary Arterial Hypertension Patients
Domingo, Enric
Grignola, Juan C.
Calabuig, Alvaro
Hoyos, Santiago Perez
Messeguer, Manuel Lopez
Roman, Antonio
[J]. CIRCULATION, 2019, 140
[48] Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review
Lokhorst, Chantal
van der Werf, Sjoukje
Berger, Rolf M. F.
Douwes, Johannes M.
[J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (13):
[49] Risk Stratification in Patients with Pulmonary Arterial Hypertension under Treatment - Results of Four German Centers
Stubbe, Beate
Halank, Michael
Seyfarth, Hans-Jurgen
Obst, Anne
Desole, Susanna
Opitz, Christian F.
Ewert, Ralf
[J]. PNEUMOLOGIE, 2022, 76 (05): : 330 - 339
[50] High-level clinical research promotes the development of risk stratification for pulmonary arterial hypertension
Lu, Dan
Zhang, Jiexin
Cheng, Chunyan
Yang, Yinjian
Liu, Tengfei
Zhang, Suxin
Qiu, Baochen
Li, Xianmei
Guo, Fan
Li, Jingyi
Xu, Xiqi
Sun, Kai
Jing, Zhicheng
[J]. CHINESE SCIENCE BULLETIN-CHINESE, 2024, 69 (13): : 1715 - 1724

← 1 2 3 4 5 →